News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,419 Results
Type
Article (14264)
Company Profile (282)
Press Release (253873)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79791)
Career Advice (154)
Deals (13290)
Drug Delivery (35)
Drug Development (50548)
Employer Resources (31)
FDA (5735)
Job Trends (5169)
News (144841)
Policy (10052)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (918)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (21723)
ALS (63)
Alzheimer's disease (849)
Antibody-drug conjugate (ADC) (96)
Approvals (5758)
Artificial intelligence (121)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4594)
BIOSECURE Act (6)
Biosimilars (42)
Biotechnology (233)
Bladder cancer (49)
Brain cancer (20)
Breast cancer (150)
Cancer (1408)
Cardiovascular disease (116)
Career advice (134)
Career pathing (2)
CAR-T (112)
Cell therapy (317)
Cervical cancer (8)
Clinical research (41098)
Collaboration (534)
Compensation (256)
Complete response letters (13)
COVID-19 (1035)
CRISPR (39)
C-suite (158)
Cystic fibrosis (76)
Data (1451)
Denatured (11)
Depression (29)
Diabetes (133)
Diagnostics (1300)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (84)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (89)
Earnings (29884)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48515)
Executive appointments (450)
FDA (6410)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (495)
Gene editing (93)
Generative AI (10)
Gene therapy (241)
GLP-1 (365)
Government (1082)
Grass and pollen (2)
Guidances (19)
Healthcare (6622)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (89)
Indications (20)
Infectious disease (1100)
Inflammatory bowel disease (112)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (64)
Interviews (17)
IPO (7302)
IRA (11)
Job creations (863)
Job search strategy (128)
Kidney cancer (7)
Labor market (5)
Layoffs (206)
Leadership (3)
Legal (1389)
Liver cancer (31)
Lung cancer (202)
Lymphoma (96)
Machine learning (2)
Management (7)
Manufacturing (134)
MASH (51)
Medical device (2657)
Medtech (2658)
Mergers & acquisitions (6311)
Metabolic disorders (381)
Multiple sclerosis (52)
NASH (13)
Neurodegenerative disease (63)
Neuropsychiatric disorders (25)
Neuroscience (1244)
NextGen: Class of 2025 (2026)
Non-profit (858)
Northern California (1663)
Now hiring (22)
Obesity (192)
Opinion (102)
Ovarian cancer (61)
Pain (41)
Pancreatic cancer (54)
Parkinson's disease (119)
Partnered (8)
Patents (125)
Patient recruitment (73)
Peanut (35)
People (25681)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14516)
Phase II (19117)
Phase III (12091)
Pipeline (782)
Policy (44)
Postmarket research (852)
Preclinical (6094)
Press Release (30)
Prostate cancer (59)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (287)
Real estate (1432)
Recruiting (12)
Regulatory (8623)
Reports (15)
Research institute (941)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (58)
Series A (97)
Series B (62)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1450)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1977)
State (1)
Stomach cancer (4)
Supply chain (22)
Tariffs (6)
The Weekly (36)
United States (12908)
Vaccines (208)
Venture capitalists (32)
Weight loss (109)
Women's health (15)
Worklife (2)
Date
Today (106)
Last 7 days (309)
Last 30 days (1459)
Last 365 days (19531)
2025 (5777)
2024 (20594)
2023 (22458)
2022 (26887)
2021 (27911)
2020 (23473)
2019 (16337)
2018 (11811)
2017 (13808)
2016 (11876)
2015 (14384)
2014 (10425)
2013 (7497)
2012 (7540)
2011 (7631)
2010 (7437)
Location
Africa (149)
Alabama (41)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17353)
Australia (2936)
California (3766)
Canada (1115)
China (343)
Colorado (145)
Connecticut (149)
Delaware (96)
Europe (37228)
Florida (452)
Georgia (116)
Idaho (16)
Illinois (226)
India (10)
Indiana (91)
Iowa (1)
Japan (73)
Kansas (61)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (464)
Massachusetts (2974)
Michigan (70)
Minnesota (144)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (942)
New Mexico (12)
New York (1013)
North Carolina (542)
North Dakota (4)
Northern California (1663)
Ohio (111)
Oklahoma (9)
Oregon (21)
Pennsylvania (714)
Puerto Rico (5)
Rhode Island (18)
South America (208)
South Carolina (4)
Southern California (1450)
Tennessee (25)
Texas (436)
Utah (50)
Virginia (76)
Washington D.C. (30)
Washington State (343)
Wisconsin (14)
268,419 Results for "apollo therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
January 21, 2025
·
4 min read
Press Releases
IBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system plus a second one in option to be installed in India
March 4, 2025
·
3 min read
Press Releases
Topline Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 in Patients with Early Alzheimer’s Disease Carrying Two Copies of APOE4 Gene
April 10, 2025
·
13 min read
Press Releases
Alzheon to Present Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 at Dedicated Symposium at ADPD Conference in Vienna on April 1st, 2025
March 18, 2025
·
10 min read
Corin Group Announces Clinical Use of Apollo™ Robotic-Assisted Surgical Platform
Corin Group, a pioneer in orthopaedic innovation, announced the successful completion of first cases using the Apollo™ platform and ApolloKnee™ software for robotic-assisted total knee arthroplasty.
May 2, 2024
·
2 min read
Press Releases
Apollo Therapeutics Signs Exclusive Ex-China License From Sunshine Lake Pharma for Clinical-Stage FGF21 / GLP-1 Dual Receptor Agonist, a Therapeutic With Major Commercial Potential in Multiple Indications
November 12, 2024
·
6 min read
Genetown
Apollo Therapeutics Announces Second Close of Series C Financing Bringing Total Raised in Round to $260 Million
Apollo Therapeutics announces that during December 2023 it completed a second close of its Series C financing, raising an additional $33.5 million and bringing the total raised in this round by the Company during 2023 to $260 million.
January 2, 2024
·
3 min read
Press Releases
Alzheon Announces Two New Scientific Papers Ahead of APOLLOE4 Phase 3 Trial Topline Symposium at ADPD Conference in Vienna on April 1st, Marking 15 Pathbreaking Peer-Reviewed Publications from Alzheon
February 25, 2025
·
11 min read
Drug Development
Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies
Marker Therapeutics, Inc. reported that Geoffrey Shouse, D.O., Ph.D., the Principal Investigator at City of Hope National Medical Center in Duarte, CA, was invited to present his clinical experience from the APOLLO study at the 11th Global Summit on Hematologic Malignancies in Whistler, BC, Canada.
April 8, 2024
·
8 min read
Biotech Bay
Apollo Hospital in New Delhi Initiates First Non-Invasive ZAP-X Brain Tumor Treatment in South Asia
ZAP Surgical Systems, Inc. announced that Apollo Hospital in New Delhi, India, completed its first patient treatment using the new ZAP-X® Gyroscopic Radiosurgery® platform.
March 7, 2024
·
4 min read
1 of 26,842
Next
